AVICEDA THERAPEUTICS, INC.

Profile

Company Names

AVICEDA THERAPEUTICS, INC.
AVICEDA OPHTHALMICS, INC.

Addresses

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-332-0741

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$124,108,493.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-12-17 
$74,999,940.00 
$207,499,882.00 
$132,499,942.00 
Equity 
5
2024-05-17 
$18,899,969.00 
$27,700,000.00 
$8,800,031.00 
Equity 
4
2023-05-05 
$15,610,000.00 
$15,610,000.00 
$0.00 
Equity 
3
2022-03-11 
$8,398,584.00 
$26,200,000.00 
$17,801,416.00 
Equity 
2
2021-07-14 
$1,950,000.00 
$1,950,000.00 
$0.00 
Debt 
1
2020-02-26 
$4,250,000.00 
$4,250,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPH 
 
ADAMS 
DIRECTOR
AVICEDA THERAPEUTICS, INC.
DAVID 
 
CALLANAN 
EXECUTIVE OFFICER
AVICEDA THERAPEUTICS, INC.
MOHAMED 
 
GENEAD 
EXECUTIVE OFFICER, DIRECTOR
AVICEDA OPHTHALMICS, INC.   |  AVICEDA THERAPEUTICS, INC.
MOHAMED 
A. 
GENEAD 
EXECUTIVE OFFICER, DIRECTOR
AVICEDA OPHTHALMICS, INC.
DAVID 
 
GUYER 
DIRECTOR
NEOVISTA INC   |  LUX BIOSCIENCES INC   |  OPHTHOTECH CORP.   |  LINK MEDICINE CORP   |  PANOPTICA, INC.   |  ALLOCURE INC   |  SOUND PHARMACEUTICALS INC   |  INVECTYS, INC.   |  AVICEDA THERAPEUTICS, INC.   |  LIFE BIOSCIENCES LLC
TAREK 
 
HASSAN 
EXECUTIVE OFFICER
AVICEDA THERAPEUTICS, INC.
PATRICK 
 
JOHNSON 
DIRECTOR
MAX-WELLNESS, LLC   |  BIOPHOTAS, INC.   |  FRONTIER COMMUNITY BANCSHARES, INC.   |  SYDNEXIS, INC.   |  AVICEDA THERAPEUTICS, INC.
DEREK 
 
KUNIMOTO 
EXECUTIVE OFFICER, DIRECTOR
AVICEDA OPHTHALMICS, INC.   |  AVICEDA THERAPEUTICS, INC.
ERIN 
 
LAVELLE 
DIRECTOR
ELIEM THERAPEUTICS, INC.   |  AVICEDA THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.
NANCY 
 
THOMASON 
DIRECTOR
AVICEDA THERAPEUTICS, INC.
MICHAEL 
 
TOLENTINO 
DIRECTOR, EXECUTIVE OFFICER
PANTHER PHARMACEUTICALS, INC.   |  AVICEDA OPHTHALMICS, INC.   |  BESPOKE, INC.   |  AVICEDA THERAPEUTICS, INC.
PAUL 
 
VUKELIC 
DIRECTOR
AVICEDA THERAPEUTICS, INC.
JAY 
 
WOODS 
DIRECTOR
AVICEDA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-17 
2024-05-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-17 
2023-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-05 
2022-03-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-11 
2021-08-12
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2021-07-14 
2020-09-16
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2020-02-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011